-
Genzyme (again) turns down Sanofi-Aventis
CAMBRIDGE, Mass. — Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.
The offer has been extended until Jan. 11, Genzyme said.
Sanofi has sought to buy Genzyme since August. Genzyme, based in Cambridge, Mass., specializes in treatments for rare genetic disorders, such as Fabry disease and Gaucher disease.
-
Pepsi raises stake in coconut water company
PURCHASE, N.Y. — PepsiCo has upped its investment in O.N.E., a coconut water company.
Terms of the transaction were not disclosed, but PepsiCo noted that it now has the majority stake in the company.
"Coconut water is one of the fastest-growing categories in the U.S. beverage market, and one in which we see a great deal of potential. Our investment in O.N.E. is an investment in the future," said Massimo d'Amore, CEO of PepsiCo Beverages Americas.